Lock-Up Agreement Skye Bioscience, Inc.Lock-Up Agreement • January 31st, 2024 • 5AM Partners VII, LLC • Pharmaceutical preparations
This letter is being delivered to you in connection with the proposed Securities Purchase Agreement (the “Purchase Agreement”), providing for the sale and issuance of shares of common stock of Skye Bioscience, Inc. (the “Company”), par value $0.001 per share (the “Common Stock”)[, and other securities convertible into, or exercisable or exchangeable for shares of the Company’s Common Stock] (the “Private Placement”), and for which Piper Sandler & Co. and Oppenheimer & Co. Inc. are acting as placement agents (the “Placement Agents”). Capitalized terms used herein have the respective meanings ascribed thereto in the Purchase Agreement unless otherwise defined herein.
